Mumbai, India

Sharat Chandran

This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sharat Chandran: Innovator in Biomarker Segmentation

Introduction

Sharat Chandran is a notable inventor based in Mumbai, India. He has made significant contributions to the field of biomarker segmentation through his innovative methods and technologies. His work focuses on enhancing the analysis of stained regions in biological samples, which is crucial for various medical applications.

Latest Patents

Sharat Chandran holds a patent for a method titled "High-throughput biomarker segmentation utilizing hierarchical normalized cuts." This invention involves a sophisticated approach to obtaining segmented images of stained regions. The process includes quantifying the presence of biomarkers in original images, selecting data based on user-specified domain knowledge, and clustering the data through a frequency weighted mean shift. The invention culminates in creating a final image that is stored for further analysis.

Career Highlights

Chandran is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical diagnostics and research methodologies.

Collaborations

Some of his notable coworkers include Andrew Janowczyk and Anant Madabhushi, who contribute to the collaborative efforts in research and development within the field.

Conclusion

Sharat Chandran's contributions to biomarker segmentation exemplify the intersection of technology and medicine. His innovative methods are paving the way for advancements in medical analysis and diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…